Chemomab Therapeutics Ltd. American Depositary Share — gráfico, cotizaciones y noticias (NASDAQ:CMMB) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Market Capitalization 12.1549 M
Employee 12
Founded 2011
CEO N/A
Website www.chemomab.com
Headquarter Israel
FIGI BBG00N0PMGK1
Industry Technology

Ingresos totales

Beneficio neto

Beneficio básico por acción

Deuda total

Flujo de caja libre

Efectivo y equivalentes

12.15 M Capitalización de mercado

Noticias

Nebokitug de Chemomab muestra potencial modificador de la enfermedad en ensayo de PSC

Chemomab’s nebokitug shows disease-modifying potential in PSC trial

Chemomab reporta datos positivos a 48 semanas para nebokitug en PSC

Chemomab reports positive 48-week data for PSC drug nebokitug

ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition

Best Momentum Stocks to Buy for Oct. 23

New Strong Buy Stocks for Oct. 23: MQ, GES and More

SNY's Efdoralprin Alfa Meets Key Endpoints in Rare Disease Study

Roche's Gazyva Secures FDA Nod for Label Expansion in Lupus Nephritis

NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients

ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up

NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs